Biovail Settles Canadian Cardizem Suit
Pharmaceutical company Biovail Corp. has put another shareholder class action behind it, agreeing to settle with a Canadian pension fund that claimed the company made misleading statements in promoting its hypertension...To view the full article, register now.
Already a subscriber? Click here to view full article